Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB25FFQUU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,122
Award facts
- Contract value 100% obligated
- $17,122.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Dupixent (dupilumab) 300 mg/2 mL pen injections with a ceiling value of $17,122.24 under a firm fixed-price contract type. The award was made on September 22, 2025, with an ultimate completion date of September 23, 2025, and carries no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfilled the order from its corporate office location. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026.
The IDC serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. Dupixent, a specialty medication used primarily for treating moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma, represents one of many specialty pharmaceutical products the contractor delivers through this contract. The competitive, non-set-aside award reflects AmerisourceBergen's established capability to meet federal medical procurement requirements. DLA Troop Support is planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, indicating AmerisourceBergen's continued role as a critical vendor for Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FFQUU?
SPE2DB25FFQUU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 22, 2025.
How much is contract SPE2DB25FFQUU worth?
The government has obligated $17,122 on SPE2DB25FFQUU.
Is contract SPE2DB25FFQUU an order under another contract?
Yes. SPE2DB25FFQUU is a delivery order under SPE2DB24D3013, an indefinite delivery contract.
Was contract SPE2DB25FFQUU competed?
The extent of competition for SPE2DB25FFQUU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award